Tachycardia aggravated and Syncope aggravated

Summary:

Syncope aggravated is found among people with Tachycardia aggravated, especially for people who are female, 60+ old.

The study analyzes which people have Syncope aggravated with Tachycardia aggravated. It is created by eHealthMe based on reports of 493 people who have Tachycardia aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Tachycardia aggravated?

Tachycardia aggravated (a heart rate that exceeds the normal range) is found to be associated with 3,009 drugs and 2,275 conditions by eHealthMe. Check the latest studies of Tachycardia aggravated.

What is Syncope aggravated?

Syncope aggravated (a loss of consciousness with an inability to maintain postural tone) is found to be associated with 1,690 drugs and 590 conditions by eHealthMe. Check the latest studies of Syncope aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

493 people who have Tachycardia Aggravated and Syncope Aggravated are studied.

Would you have Syncope aggravated when you have Tachycardia aggravated?

Gender of people who have Tachycardia aggravated and experienced Syncope aggravated *:

Click here to view

Age of people who have Tachycardia aggravated and experienced Syncope aggravated *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Syncope aggravated?

- Check whether Syncope aggravated is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Tachycardia aggravated (22 reports)
Syncope aggravated (17 reports)

All the drugs that are associated with Syncope aggravated:

Syncope aggravated (1,690 drugs)

All the conditions that are associated with Syncope aggravated:

Syncope aggravated (590 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Syncope aggravated and Tachycardia aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.